Literature DB >> 22754193

Correlation between proinflammatory serum markers: high sensitivity C-reactive protein, interleukin-6 with disability score in acute ischemic stroke.

Anuradha Bharosay, Kiran Saxena, Meena Varma, Vivek Vikram Bharosay, Aparna Pandey.   

Abstract

Stroke being the third leading cause of death and foremost cause of disability, if potential diagnostic utility of blood borne protein biomarkers in predicting acute stroke is established, it would be a substantial adjunct to computerized tomography and magnetic resonance imaging which have their own limitations. This study was done to correlate serum Interleukin 6, high sensitivity C reactive protein at the time of admission with neurological worsening assessed by NIHSS at the time of admission and 7 days after admission. 46 Patients admitted in neurology department SAIMS, Indore with first ever ischemic stroke within 72 h of onset were included in the study. All patients with history of stroke of more than 72 h onset, Infection & peripartum stroke were excluded from the study. Disability scoring was done by NIHSS and their serum samples assayed for hsCRP, IL6 by commercially available quantitative sandwich enzyme-linked immunoadsorbent assay kits. Serum samples of 50 control cases which included healthy volunteers and staff from SAIMS were also analyzed for hsCRP, IL6 for comparative study. A significant correlation was observed between NIHSS scoring and serum hsCRP and IL6 at the time of admission. Patients with initial high serum IL6 and hsCRP also showed significant clinical deterioration as assessed by NIHSS scoring 7 days after admission. Elevated hsCRP and IL6 within 72 h of admission strongly correlated with functional disability in study population in India and may serve as useful adjunct to CT Scan in emergency setting.

Entities:  

Keywords:  Disability score; High sensitive C-Reactive Protein; Interleukin-6; Ischemic stroke; National Institute of Health Stroke Scale

Year:  2011        PMID: 22754193      PMCID: PMC3162955          DOI: 10.1007/s12291-011-0135-1

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  25 in total

1.  A prospective community-based study of stroke in Kolkata, India.

Authors:  Shyamal K Das; Tapas K Banerjee; Atanu Biswas; Trishit Roy; Deepak K Raut; Chandra S Mukherjee; Arijit Chaudhuri; Avijit Hazra; Jayanta Roy
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

2.  Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population.

Authors:  In-Uk Song; Joong-Seok Kim; Yeong-In Kim; Kwang-Soo Lee; Du-Shin Jeong; Sung-Woo Chung
Journal:  Cerebrovasc Dis       Date:  2009-10-16       Impact factor: 2.762

Review 3.  Stroke in the developing world.

Authors:  N Poungvarin
Journal:  Lancet       Date:  1998-10       Impact factor: 79.321

4.  Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke.

Authors:  M Di Napoli; F Papa; V Bocola
Journal:  Stroke       Date:  2001-01       Impact factor: 7.914

5.  Molecular signatures of brain injury after intracerebral hemorrhage.

Authors:  J Castillo; A Dávalos; J Alvarez-Sabín; J M Pumar; R Leira; Y Silva; J Montaner; C S Kase
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

Review 6.  C-reactive protein, stroke, and statins.

Authors:  Allan D Angerio; Matthew F Bialko; Bradley M White
Journal:  Crit Care Nurs Q       Date:  2007 Apr-Jun

7.  C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease.

Authors:  David Tanne; Michal Benderly; Uri Goldbourt; Moti Haim; Alexander Tenenbaum; Enrique Z Fisman; Zipora Matas; Yehuda Adler; Reuven Zimmlichman; Solomon Behar
Journal:  Stroke       Date:  2006-06-01       Impact factor: 7.914

8.  Morbidity predictors in ischemic stroke.

Authors:  J N Panicker; M Thomas; K Pavithran; D Nair; P S Sarma
Journal:  Neurol India       Date:  2003-03       Impact factor: 2.117

9.  Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke.

Authors:  Kerstin Winbeck; Holger Poppert; Thorleif Etgen; Bastian Conrad; Dirk Sander
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

10.  Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome.

Authors:  Craig J Smith; Hedley C A Emsley; Carole M Gavin; Rachel F Georgiou; Andy Vail; Elisa M Barberan; Gregory J del Zoppo; John M Hallenbeck; Nancy J Rothwell; Stephen J Hopkins; Pippa J Tyrrell
Journal:  BMC Neurol       Date:  2004-01-15       Impact factor: 2.474

View more
  5 in total

1.  Gene Variant and Level of IL-1β in Ischemic Stroke Patients With and Without Type 2 Diabetes Mellitus.

Authors:  Khouloud Chehaibi; Mohamed Yahia Hrira; Imen Trabelsi; Juan Carlos Escolà-Gil; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2015-07-09       Impact factor: 3.444

2.  Neuron specific enolase and c-reactive protein levels in stroke and its subtypes: correlation with degree of disability.

Authors:  Aparna Pandey; Amit Kumar Shrivastava; Kiran Saxena
Journal:  Neurochem Res       Date:  2014-05-17       Impact factor: 3.996

3.  Interleukin-6, a reliable prognostic factor for ischemic stroke.

Authors:  Sheyda Shaafi; Ehsan Sharifipour; Rouhollah Rahmanifar; SeyedShamseddin Hejazi; Sasan Andalib; Masoud Nikanfar; Behzad Baradarn; Robab Mehdizadeh
Journal:  Iran J Neurol       Date:  2014-04-03

4.  Investigating the relationship between interleukin-6 serum levels and outcome in acute ischemic CVA.

Authors:  Arash Mosarrezaii; Mohammad Reza Amiri-Nikpour; Hamid Reza Mehryar; Babak Choobi Anzali; Sarmad Nourooz-Zadeh; Shadi Babaei; Hedieh Farrokhi
Journal:  Brain Behav       Date:  2020-06-25       Impact factor: 2.708

5.  The relationship between the severity of disability and serum IL-8 in acute ischemic stroke patients.

Authors:  Hala A Shaheen; Lamiaa I Daker; Mohammed M Abbass; Asmaa A Abd El Fattah
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.